ALC Stock Recent News
ALC LATEST HEADLINES
Alcon (ALC) is witnessing growth in its over-the-counter portfolio, mainly driven by favorable pricing and a sustained family of products.
Alcon (ALC) announces the closing of its deal to acquire BELKIN Vision. Per the terms of the agreement, Alcon will have access to BELKIN Vision's Direct Selective Laser Trabeculoplasty technology.
Alcon (ALC) gets FDA 510(k) clearance for its Unity VCS and Unity CS. The company will start a thorough program to get real-world feedback before the systems' commercial launch in 2025.
GENEVA--(BUSINESS WIRE)--Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance.
GENEVA--(BUSINESS WIRE)--Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
New product launches and strong solvency bode well for Alcon (ALC).
Here is how Alcon (ALC) and CalciMedica Inc. (CALC) have performed compared to their sector so far this year.
ST. CATHARINES, Ontario--(BUSINESS WIRE)-- #yourmarinecarrierofchoice--Algoma Central Corporation (TSX: ALC) (TSX: ALC.DB.A) announced today that following the second quarter dividend of $0.19 per common share, an adjustment has been made to the conversion price of the convertible debentures, reducing it to $14.10. The convertible debentures have a maturity date of June 30, 2024. The second quarter dividend will be paid on June 3, 2024 to shareholders of record on May 17, 2024. About Algoma Central Corporation Algoma Centr.
Alcon's (ALC) Q1 results reflect substantial growth in its franchises on the back of healthy markets.